Technical Analysis for SCTL - Societal CDMO, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 1.10 | 0.00% | 0.00 |
SCTL closed unchanged on Monday, April 8, 2024, on 0 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Health Sciences Logistics Services Pharmacology Tablet Contract Manufacturing Organization Liposome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Health Sciences Logistics Services Pharmacology Tablet Contract Manufacturing Organization Liposome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.27 |
| 52 Week Low | 0.26 |
| Average Volume | 1,224,277 |
| 200-Day Moving Average | 0.61 |
| 50-Day Moving Average | 0.79 |
| 20-Day Moving Average | 1.09 |
| 10-Day Moving Average | 1.09 |
| Average True Range | 0.02 |
| RSI (14) | 73.96 |
| ADX | 63.33 |
| +DI | 32.75 |
| -DI | 6.98 |
| Chandelier Exit (Long, 3 ATRs) | 1.03 |
| Chandelier Exit (Short, 3 ATRs) | 1.13 |
| Upper Bollinger Bands | 1.11 |
| Lower Bollinger Band | 1.07 |
| Percent B (%b) | 0.83 |
| BandWidth | 3.46 |
| MACD Line | 0.08 |
| MACD Signal Line | 0.10 |
| MACD Histogram | -0.021 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.10 | ||||
| Resistance 3 (R3) | 1.10 | 1.10 | 1.10 | ||
| Resistance 2 (R2) | 1.10 | 1.10 | 1.10 | 1.10 | |
| Resistance 1 (R1) | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 |
| Pivot Point | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 |
| Support 1 (S1) | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 |
| Support 2 (S2) | 1.10 | 1.10 | 1.10 | 1.10 | |
| Support 3 (S3) | 1.10 | 1.10 | 1.10 | ||
| Support 4 (S4) | 1.10 |
